When to sell UNH
The honest answer to "when should I sell UnitedHealth Group Inc" is not a price target. It is the moment the reasons you bought it stop being true. Here is a thesis-based checklist for UNH holders.
The UNH sell checklist
- 1Did a reason break, or just the price? A drawdown with your thesis intact is not a sell signal. A contradicted pillar is.
- 2Check the latest filing and earnings Read what changed against your reasons for owning UNH, not against the stock chart.
- 3Look for the specific risks UNH's known risks are below. Watch for any of them turning from possibility into fact.
- 4Re-underwrite, do not anchor If a reason is gone, decide whether you would buy UNH today on what remains. If not, the position is a hold by inertia.
What you bought UNH for
Some investors cite UnitedHealth's robust revenue growth of 11.81% year-over-year as a sign of strong operational performance. Additionally, the company's market cap of $378.01B positions it well for further expansion in the healthcare sector.
The signals that would break it
Conversely, the decline in EPS by 14.70% year-over-year raises concerns about profitability. Furthermore, the P/E ratio of 31.36 may indicate that the stock is considered relatively expensive compared to historical averages.
Where UNH stands now
UnitedHealth Group Inc has a market capitalization of $378.01B and is currently trading at $414.94, reflecting a 1.02% increase from the previous close of $410.76. The company's P/E ratio stands at 31.36, with a P/S ratio of 0.84 and a P/B ratio of 3.78. Year-over-year revenue growth is 11.81%, while EPS growth has declined by 14.70%. The dividend yield is 2.09%, and the stock has a 52-week range between $256 and $461.
The hard part is noticing
Everyone agrees you should sell when the reasons change. The problem is that the evidence lives in filings and earnings calls, while you spend your attention on the price. Helm closes that gap: you write the reasons you own UNH, and Helm watches the primary sources against them, then tells you with a dated citation when one breaks. See how thesis monitoring works, or read what could invalidate the UNH thesis.
Common questions
When should I sell UNH?
Sell UnitedHealth Group Inc when the specific reasons you bought it are contradicted by a filing, an earnings result, or a material news event, not merely when the price falls. A lower price with the thesis intact is a different situation from a broken thesis.
What are the warning signs for UNH?
The main risks to watch: Conversely, the decline in EPS by 14.70% year-over-year raises concerns about profitability. Furthermore, the P/E ratio of 31.36 may indicate that the stock is considered relatively expensive compared to historical averages.
Is a falling UNH price a reason to sell?
Not by itself. Price is not a reason. The question is whether the reasons you own UNH still hold. If they do, a drawdown may be noise; if they do not, the position deserves a fresh decision regardless of price.
Know the moment, not the price.
Helm tells you, with a dated source, when the UNH thesis breaks. Free to start.
Take the helmThis content is for educational purposes only and does not constitute financial, tax, or investment advice. Helm Terminal is not a registered investment advisor.